RYTMRhythm Pharmaceuticals, Inc.

$90.85-5.4% 1Y

Is it growing?

Good

Growing: revenue growing +54% year on year and operating margin widening (+31.9 points).

2 good, 1 without data
Revenue trend+54% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+31.9 points operating

Trailing-twelve-month operating margin, -85.0% now against -116.9% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is RYTM growing?

Rhythm Pharmaceuticals, Inc. has grown revenue 100% a year over three years.

+100%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Years of annual history on file
11

Years of annual history on file · FY2015 to FY2025, as filed

Details›
Revenue FY2021
$3.2M
Revenue FY2022
$24M
Revenue FY2023
$77M
Revenue FY2024
$130M
Revenue FY2025
$190M

Annual income statements as filed with the SEC.